pf 1022a has been researched along with Helminthiasis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fraatz, K; Harder, A; Krebber, R; Krücken, J; Kulke, D; Mehlhorn, H; VON Samson-Himmelstjerna, G | 1 |
| Amliwala, K; Harder, A; Holden-Dye, L; Krücken, J; Marinovski, P; Schmitt-Wrede, HP; Walker, R; Willson, J; Wunderlich, F | 1 |
1 review(s) available for pf 1022a and Helminthiasis
| Article | Year |
|---|---|
Cyclooctadepsipeptides--an anthelmintically active class of compounds exhibiting a novel mode of action.
Topics: Animals; Anthelmintics; Binding Sites; Depsipeptides; Drug Resistance; Helminth Proteins; Helminthiasis; Helminthiasis, Animal; Helminths; Humans; Nematoda; Peptides, Cyclic; Phylogeny | 2003 |
1 other study(ies) available for pf 1022a and Helminthiasis
| Article | Year |
|---|---|
In vivo efficacy of PF1022A and nicotinic acetylcholine receptor agonists alone and in combination against Nippostrongylus brasiliensis.
Topics: Animals; Anthelmintics; Depsipeptides; Drug Therapy, Combination; Female; Helminthiasis; Microscopy, Electron, Scanning; Nippostrongylus; Rats; Rats, Wistar; Treatment Outcome | 2013 |